Skip to main content
Clinical Trials/NCT04800900
NCT04800900
Completed
N/A

Effectiveness of Pharmaceutical Interventions in the Omission of Prescription and Desprescription of Medications in Hospitalized Patients

Federal University of Bahia1 site in 1 country332 target enrollmentFebruary 4, 2021
ConditionsSafety Issues

Overview

Phase
N/A
Intervention
Not specified
Conditions
Safety Issues
Sponsor
Federal University of Bahia
Enrollment
332
Locations
1
Primary Endpoint
Effectiveness of pharmaceutical interventions measured by proportion of accepted interventions and all interventions
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The presence of multimorbidities is very common among the elderly, which become major consumers of medicines. The process of prescribing medicines for the elderly should be done with caution, as the use of some medications may present more risks than benefits in this range age. Potentially inappropriate prescribing for the elderly has become a global concern for the promotion of an adequate pharmacotherapy, it becomes essential to be aware of the effectiveness and safety of medicines and the knowledge of which drugs whose risks of serious adverse reactions outweigh the benefit of your referral. In this sense, the present study has aim to evaluate the effectiveness of pharmaceutical interventions in frequency of omission of drugs with proven efficacy for cardiovascular diseases and promotion of treatment prescription inappropriate and polypharmacy. A prospective quasi experimental before and after study will be carried out in elderly patients diagnosed with cardiovascular disease admitted to the Ana Nery hospital, Salvador, Bahia, Brazil. A convenience sample will be collected, the data will be released and revised in a database built in the SPSS software and analyzed in the program statistic R and SPSS. At the end of the study, it is expected a decrease in the frequency of omission of medications and promotion of prescription drugs inappropriate.

Registry
clinicaltrials.gov
Start Date
February 4, 2021
End Date
January 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Federal University of Bahia
Responsible Party
Principal Investigator
Principal Investigator

Márcio Galvão Guimarães de Oliveira

Clinical Professor of Pharmacy and Evidence-based Health Care

Federal University of Bahia

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of cardiovascular disease
  • Discharge after 24 hours

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effectiveness of pharmaceutical interventions measured by proportion of accepted interventions and all interventions

Time Frame: The acceptance of all pharmaceutical interventions related to inappropriate prescribed drugs and omission of prescription during the hospitalization of the patient will be evaluated, through study completion, an average of 1 year

Secondary Outcomes

  • Incidence of omission of prescription drugs with proven efficacy for cardiovascular diseases measured by the START criteria(First prescription after 24 hours of admission, last prescription and discharge prescription through study completion, an average of 1 year)
  • Incidence of polypharmacy in elderly people with cardiovascular diseases measured by prescription containing five or more drugs(First prescription after 24 hours of admission, last prescription and discharge prescription through study completion, an average of 1 year)
  • Incidence of potentially inappropriate drug prescription in elderly people with cardiovascular diseases measured by the Beers criteria(First prescription after 24 hours of admission, last prescription and discharge prescription through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials